MEDBOT-B (02252) announced that its board of directors has resolved to nominate Dr. Chang Zhaohua, Mr. Shirafuji Taiji, Mr. Ashida Norihiro, and Ms. Liang Min as non-executive directors. Additionally, the board has nominated Mr. Zhou Jiahong and Dr. Liu Guoen as independent non-executive directors.

Mr. Sun Hongbin has resigned from his positions as non-executive director, chairman of the board, chairman of the Strategy and Development Committee, member of the Remuneration and Assessment Committee, and member of the Commercialization Committee due to the need to focus on other professional commitments. His resignation will take effect upon the conclusion of the upcoming extraordinary general meeting.

Ms. Fang Cong has resigned from her roles as executive director and member of the Nomination Committee for the same reason, with her resignation also effective at the end of the forthcoming extraordinary general meeting.

Dr. Li Minghua has stepped down as independent non-executive director, chairman of the Remuneration and Assessment Committee, member of the Audit Committee, member of the Nomination Committee, and member of the Strategy and Development Committee, citing similar reasons. His resignation will take effect upon the conclusion of the upcoming extraordinary general meeting.